1987 …2024

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2019

Gemcitabine and metabolite pharmacokinetics in advanced NSCLC patients after bronchial artery infusion and intravenous infusion

Alharbi, A. F., Kratzke, R. A., D’Cunha, J., Maddaus, M. A., Sanghavi, K. & Kirstein, M. N., Feb 5 2019, In : Cancer chemotherapy and pharmacology. 83, 2, p. 387-391 5 p.

Research output: Contribution to journalArticle

Inhibition of oncogenic cap-dependent translation by 4EGI-1 reduces growth, enhances chemosensitivity and alters genome-wide translation in non-small cell lung cancer

De, A., Jacobson, B. A., Peterson, M. S., Stelzner, M. E., Jay-Dixon, J., Kratzke, M. G., Patel, M. R., Bitterman, P. B. & Kratzke, R. A., May 1 2019, In : Cancer gene therapy. 26, 5-6, p. 157-165 9 p.

Research output: Contribution to journalArticle

1 Scopus citations

JAK/STAT inhibition with ruxolitinib enhances oncolytic virotherapy in non-small cell lung cancer models

Patel, M. R., Dash, A., Jacobson, B. A., Ji, Y., Baumann, D., Ismail, K. & Kratzke, R. A., Nov 1 2019, In : Cancer gene therapy. 26, 11-12, p. 411-418 8 p.

Research output: Contribution to journalArticle

7 Scopus citations

LACE-Bio: Validation of Predictive and/or Prognostic Immunohistochemistry/Histochemistry-based Biomarkers in Resected Non–small-cell Lung Cancer

LACE-Bio Steering Committee, Mar 2019, In : Clinical Lung Cancer. 20, 2, p. 66-73.e6

Research output: Contribution to journalArticle

4 Scopus citations
2018

4EGI-1 represses cap-dependent translation and regulates genome-wide translation in malignant pleural mesothelioma

De, A., Jacobson, B. A., Peterson, M. S., Jay-Dixon, J., Kratzke, M. G., Sadiq, A. A., Patel, M. R. & Kratzke, R. A., Apr 1 2018, In : Investigational New Drugs. 36, 2, p. 217-229 13 p.

Research output: Contribution to journalArticle

3 Scopus citations

Asbestos-Related Disease

Kratzke, P. & Kratzke, R. A., Jan 1 2018, (Accepted/In press) In : Journal of Radiology Nursing.

Research output: Contribution to journalArticle

2 Scopus citations

Genome-wide copy number analyses of samples from LACE-Bio project identify novel prognostic and predictive markers in early stage non-small cell lung cancer

on behalf of the LACE-Bio Consortium, Jun 1 2018, In : Translational Lung Cancer Research. 7, 3, p. 416-427 12 p.

Research output: Contribution to journalArticle

3 Scopus citations

Meet the new boss: Lung cancer staging

Begnaud, A. & Kratzke, R. A., Mar 1 2018, In : Journal of Thoracic Disease. 10, 3, p. 1329-1331 3 p.

Research output: Contribution to journalEditorial

1 Scopus citations

Smoking, sex, and non–Small cell lung cancer: Steroid hormone receptors in tumor tissue (S0424)

Cheng, T. Y. D., Darke, A. K., Redman, M. W., Zirpoli, G. R., Davis, W., Ondracek, R. P., Bshara, W., Omilian, A. R., Kratzke, R. A., Reid, M. E., Molina, J. R., Kolesar, J. M., Chen, Y., MacRae, R. M., Moon, J., Mack, P., Gandara, D. R., Kelly, K., Santella, R. M., Albain, K. S. & 1 others, Ambrosone, C. B., Jan 1 2018, In : Journal of the National Cancer Institute. 110, 7, p. 734-742 9 p.

Research output: Contribution to journalArticle

3 Scopus citations
2017

Cap-dependent translational control of oncolytic measles virus infection in malignant mesothelioma

Jacobson, B. A., Sadiq, A. A., Tang, S., Jay-Dixon, J., Patel, M. R., Drees, J., Sorenson, B. S., Russell, S. J. & Kratzke, R. A., Jan 1 2017, In : Oncotarget. 8, 38, p. 63096-63109 14 p.

Research output: Contribution to journalArticle

Open Access
4 Scopus citations

MicroRNA as Biomarkers of Malignant Mesothelioma

Hoang, C. D. & Kratzke, R. A., Jan 1 2017, Translating MicroRNAs to the Clinic. Elsevier Inc., p. 203-221 19 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Oncolytic viral therapy for mesothelioma

Pease, D. F. & Kratzke, R. A., Aug 24 2017, In : Frontiers in Oncology. 7, AUG, 179.

Research output: Contribution to journalArticle

10 Scopus citations

Pooled analysis of the prognostic and predictive effects of TP53 comutation status combined with KRAS or EGFR mutation in early-stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapy

Shepherd, F. A., Lacas, B., Le Teuff, G., Hainaut, P., Jänne, P. A., Pignon, J. P., Le Chevalier, T., Seymour, L., Douillard, J. Y., Graziano, S., Brambilla, E., Pirker, R., Filipits, M., Kratzke, R., Soria, J. C. & Tsao, M. S., Jun 20 2017, In : Journal of Clinical Oncology. 35, 18, p. 2018-2027 10 p.

Research output: Contribution to journalArticle

33 Scopus citations

Targeting eukaryotic protein translation in mesothelioma

Kratzke, R. A., Jun 1 2017, In : Translational Lung Cancer Research. 6, 3, p. 343-349 7 p.

Research output: Contribution to journalReview article

Open Access
1 Scopus citations
2 Scopus citations
2016

A 10-Gene Yin Yang Expression Ratio Signature for Stage IA and IB Non-Small Cell Lung Cancer

Xu, W., Jia, G., Davie, J. R., Murphy, L., Kratzke, R. & Banerji, S., Jan 1 2016, In : Journal of Thoracic Oncology. 11, 12, p. 2150-2160 11 p.

Research output: Contribution to journalArticle

8 Scopus citations

Detection of occult micrometastases in patients with clinical stage i non-small-cell lung cancer: A prospective analysis of mature results of CALGB 9761 (Alliance)

Martin, L. W., D'Cunha, J., Wang, X., Herzan, D., Gu, L., Abraham, N., Demmy, T. L., Detterbeck, F. C., Groth, S. S., Harpole, D. H., Krasna, M. J., Kernstine, K., Kohman, L. J., Patterson, G. A., Sugarbaker, D. J., Vollmer, R. T., Maddaus, M. A. & Kratzke, R. A., May 1 2016, In : Journal of Clinical Oncology. 34, 13, p. 1484-1491 8 p.

Research output: Contribution to journalArticle

24 Scopus citations

Prognostic effect of tumor lymphocytic infiltration in resectable non-small-cell lung cancer

Brambilla, E., Le Teuff, G., Marguet, S., Lantuejoul, S., Dunant, A., Graziano, S., Pirker, R., Douillard, J. Y., Le Chevalier, T., Filipits, M., Rosell, R., Kratzke, R., Popper, H., Soria, J. C., Shepherd, F. A., Seymour, L. & Tsao, M. S., Apr 10 2016, In : Journal of Clinical Oncology. 34, 11, p. 1223-1230 8 p.

Research output: Contribution to journalArticle

95 Scopus citations
2015

Antisense oligonucleotide targeting eukaryotic translation initiation factor 4E reduces growth and enhances chemosensitivity of non-small-cell lung cancer cells

Thumma, S. C., Jacobson, B. A., Patel, M. R., Konicek, B. W., Franklin, M. J., Jay-Dixon, J., Sadiq, A., De, A., Graff, J. R. & Kratzke, R. A., Aug 18 2015, In : Cancer gene therapy. 22, 8, p. 396-401 6 p.

Research output: Contribution to journalArticle

16 Scopus citations

Epigenetics of lung cancer

Langevin, S. M., Kratzke, R. A. & Kelsey, K. T., Jan 1 2015, In : Translational Research. 165, 1, p. 74-90 17 p.

Research output: Contribution to journalReview article

73 Scopus citations

Genetic Engineering of Oncolytic Viruses for Cancer Therapy

Patel, M. R. & Kratzke, R. A., Jan 1 2015, Translating Gene Therapy to the Clinic: Techniques and Approaches. Elsevier Inc., p. 261-279 19 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Subtype classification of lung adenocarcinoma predicts benefit from adjuvant chemotherapy in patients undergoing complete resection

Tsao, M. S., Marguet, S., Le Teuff, G., Lantuejoul, S., Shepherd, F. A., Seymour, L., Kratzke, R., Graziano, S. L., Popper, H. H., Rosell, R., Douillard, J. Y., Le-Chevalier, T., Pignon, J. P., Soria, J. C. & Brambilla, E. M., Oct 20 2015, In : Journal of Clinical Oncology. 33, 30, p. 3439-3446 8 p.

Research output: Contribution to journalArticle

114 Scopus citations
1 Scopus citations
13 Scopus citations

Vesicular stomatitis virus expressing interferon-β is oncolytic and promotes antitumor immune responses in a syngeneic murine model of non-small cell lung cancer

Patel, M. R., Jacobson, B. A., Ji, Y., Drees, J., Tang, S., Xiong, K., Wang, H., Prigge, J. E., Dash, A. S., Kratzke, A. K., Mesev, E., Etchison, R., Federspiel, M. J., Russell, S. J. & Kratzke, R. A., Jan 1 2015, In : Oncotarget. 6, 32, p. 33165-33177 13 p.

Research output: Contribution to journalArticle

37 Scopus citations
2014

Measles vaccine strains for virotherapy of non-small-cell lung carcinoma

Patel, M. R., Jacobson, B. A., Belgum, H., Raza, A., Sadiq, A., Drees, J., Wang, H., Jay-Dixon, J., Etchison, R., Federspiel, M. J., Russell, S. J. & Kratzke, R. A., Aug 2014, In : Journal of Thoracic Oncology. 9, 8, p. 1101-1110 10 p.

Research output: Contribution to journalArticle

10 Scopus citations

SLC28A3 genotype and gemcitabine rate of infusion affect dFdCTP metabolite disposition in patients with solid tumours

Khatri, A., Williams, B. W., Fisher, J., Brundage, R. C., Gurvich, V. J., Lis, L. G., Skubitz, K. M., Dudek, A. Z., Greeno, E. W., Kratzke, R. A., Lamba, J. K. & Kirstein, M. N., Jan 21 2014, In : British Journal of Cancer. 110, 2, p. 304-312 9 p.

Research output: Contribution to journalArticle

12 Scopus citations

Small-molecule inhibition of oncogenic eukaryotic protein translation in mesothelioma cells

Chen, E. Z., Jacobson, B. A., Patel, M. R., Okon, A. M., Li, S., Xiong, K., Vaidya, A. J., Bitterman, P. B., Wagner, C. R. & Kratzke, R. A., Aug 2014, In : Investigational New Drugs. 32, 4, p. 598-603 6 p.

Research output: Contribution to journalArticle

11 Scopus citations
2013

Cross-validation analysis of the prognostic significance of mucin expression in patients with resected non-small cell lung cancer treated with adjuvant chemotherapy: Results from IALT, JBR.10 and ANITA

Graziano, S. L., Lacas, B., Vollmer, R., Kratzke, R., Popper, H., Filipits, M., Seymour, L., Shepherd, F. A., Rosell, R., Veillard, A. S., Taron, M. & Pignon, J. P., Oct 1 2013, In : Lung Cancer. 82, 1, p. 149-155 7 p.

Research output: Contribution to journalArticle

4 Scopus citations

Detection of mesothioloma remains a conundrum

Kratzke, R. A., Feb 20 2013, In : Journal of the National Cancer Institute. 105, 4, p. 254-255 2 p.

Research output: Contribution to journalEditorial

2 Scopus citations

ERCC1 isoform expression and DNA repair in non-small-cell lung cancer

Friboulet, L., Olaussen, K. A., Pignon, J. P., Shepherd, F. A., Tsao, M. S., Graziano, S., Kratzke, R., Douillard, J. Y., Seymour, L., Pirker, R., Filipits, M., André, F., Solary, E., Ponsonnailles, F., Robin, A., Stoclin, A., Dorvault, N., Commo, F., Adam, J., Vanhecke, E. & 8 others, Saulnier, P., Thomale, J., Le Chevalier, T., Dunant, A., Rousseau, V., Le Teuff, G., Brambilla, E. & Soria, J. C., Mar 21 2013, In : New England Journal of Medicine. 368, 12, p. 1101-1110 10 p.

Research output: Contribution to journalArticle

265 Scopus citations

Lung cancer

Kirstein, M. N., Kratzke, R. A. & Dudek, A. Z., Jul 8 2013, Koda-Kimble and Young's Applied Therapeutics: The Clinical Use of Drugs. Wolters Kluwer Health Adis (ESP), p. 2210-2222 13 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

33 Scopus citations

MiR-1 induces growth arrest and apoptosis in malignant mesothelioma

Xu, Y., Zheng, M., Merritt, R. E., Shrager, J. B., Wakelee, H. A., Kratzke, R. A. & Hoang, C. D., Nov 2013, In : Chest. 144, 5, p. 1632-1643 12 p.

Research output: Contribution to journalArticle

29 Scopus citations

Oncolytic virus therapy for cancer: The first wave of translational clinical trials

Patel, M. R. & Kratzke, R. A., Apr 2013, In : Translational Research. 161, 4, p. 355-364 10 p.

Research output: Contribution to journalReview article

61 Scopus citations

Phase II study of topotecan and bevacizumab in advanced, refractory non-small-cell lung cancer

Powell, S. F., Beitinjaneh, A., Tessema, M., Bliss, R. L., Kratzke, R. A., Leach, J. & Dudek, A. Z., Sep 1 2013, In : Clinical Lung Cancer. 14, 5, p. 495-501 7 p.

Research output: Contribution to journalArticle

10 Scopus citations

Pooled analysis of the prognostic and predictive effects of KRAS mutation status and KRAS mutation subtype in early-stage resected non–small-cell lung cancer in four trials of adjuvant chemotherapy

Shepherd, F. A., Domerg, C., Hainaut, P., Jänne, P. A., Pignon, J. P., Graziano, S., Douillard, J. Y., Brambilla, E., Le Chevalier, T., Seymour, L., Bourredjem, A., Le Teuff, G., Pirker, R., Filipits, M., Rosell, R., Kratzke, R., Bandarchi, B., Ma, X., Capelletti, M., Soria, J. C. & 1 others, Tsao, M. S., Jun 10 2013, In : Journal of Clinical Oncology. 31, 17, p. 2173-2181 9 p.

Research output: Contribution to journalArticle

153 Scopus citations
11 Scopus citations

Targeting eukaryotic translation in mesothelioma cells with an eIF4E-specific antisense oligonucleotide

Jacobson, B. A., Thumma, S. C., Jay-Dixon, J., Patel, M. R., Dubear Kroening, K., Kratzke, M. G., Etchison, R. G., Konicek, B. W., Graff, J. R. & Kratzke, R. A., Nov 18 2013, In : PloS one. 8, 11, e81669.

Research output: Contribution to journalArticle

22 Scopus citations
2012

Cross-validation study of class III beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: Analysis of four randomized trials

Reiman, T., Lai, R., Veillard, A. S., Paris, E., Soria, J. C., Rosell, R., Taron, M., Graziano, S., Kratzke, R., Seymour, L., Shepherd, F. A., Pignon, J. P. & Sève, P., Jan 1 2012, In : Annals of Oncology. 23, 1, p. 86-93 8 p., mdr033.

Research output: Contribution to journalArticle

58 Scopus citations
13 Scopus citations

CYFRA 21-1 as a prognostic and predictive marker in advanced non-small-cell lung cancer in a prospective trial: CALGB 150304

Edelman, M. J., Hodgson, L., Rosenblatt, P. Y., Christenson, R. H., Vokes, E. E., Wang, X. & Kratzke, R., Apr 1 2012, In : Journal of Thoracic Oncology. 7, 4, p. 649-654 6 p.

Research output: Contribution to journalArticle

35 Scopus citations
11 Scopus citations

Novel role of c-jun N-terminal kinase in regulating the initiation of cap-dependent translation

Patel, M. R., Sadiq, A. A., Jay-Dixon, J., Jirakulaporn, T., Jacobson, B. A., Farassati, F., Bitterman, P. B. & Kratzke, R. A., Feb 1 2012, In : International Journal of Oncology. 40, 2, p. 577-582 6 p.

Research output: Contribution to journalArticle

11 Scopus citations